CPG
BIIB icon

Custom Portfolio Group’s Biogen BIIB Stock Holding History

Custom Portfolio Group’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		$53.5K Hold
231
– – 0.04% 102
2024
Q1 		$49.8K Hold
231
– – 0.04% 106
2023
Q4 		$59.8K Buy
+231
New +$56.7K 0.05% 85

Other funds holding BIIB

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Custom Portfolio Group's BIIB Position: Q2 2024 in Review

Custom Portfolio Group held its Biogen (BIIB) position steady in Q2 2024 at 231 shares worth $53.5K. The position accounts for 0.04% of the portfolio, ranked #102.

Custom Portfolio Group first reported a position in BIIB in Q4 2023 and has held it in 3 quarters since. The position peaked at $59.8K in Q4 2023. 944 funds tracked by Wall St. Rank hold BIIB as of Q2 2024.

  • Custom Portfolio Group held 231 shares of Biogen worth $53.5K as of Q2 2024.
  • Custom Portfolio Group left its Biogen share count unchanged in Q2 2024.
  • Biogen made up 0.04% of Custom Portfolio Group's portfolio in Q2 2024, its #102 holding.
  • Custom Portfolio Group first reported a position in Biogen in Q4 2023 and has held it in 3 quarters since.
  • Custom Portfolio Group's Biogen position peaked at $59.8K in Q4 2023.
  • 944 funds tracked by Wall St. Rank held Biogen as of Q2 2024.

Based on Custom Portfolio Group's 13F filing for Q2 2024, filed 27 Aug 2024.